Related references
Note: Only part of the references are listed.Lasmiditan for the treatment of migraine
Matilde Capi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research
Todd J. Schwedt et al.
HEADACHE (2017)
Triptans and CGRP blockade - impact on the cranial vasculature
Silvia Benemei et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Min Hou et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Blocking CGRP in migraine patients - a review of pros and cons
Marie Deen et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Carlos M. Villalon et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain
Erkan Kilinc et al.
NEUROPHARMACOLOGY (2017)
Propranolol treatment prevents chronic central sensitization induced by repeated dural stimulation
Nelly Boyer et al.
PAIN (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Metoclopramide inhibits trigeminovascular activation: evidence for effective acute attack treatment in migraine
Hacer Doganay Aydin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2017)
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
Lanfranco Pellesi et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats
V. H. Aviles-Rosas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies
Dimos D. Mitsikostas et al.
CURRENT OPINION IN NEUROLOGY (2017)
Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura
Anders Hougaard et al.
BRAIN (2017)
The influence of genetic constitution on migraine drug responses
Anne Francke Christensen et al.
CEPHALALGIA (2016)
Treatment of medication-overuse headache: A systematic review
Chia-Chun Chiang et al.
CEPHALALGIA (2016)
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine
Christoph J. Schankin et al.
BRAIN (2016)
Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations
Luana Lionetto et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Medication-overuse headache: risk factors, pathophysiology and management
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2016)
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E. Bigal et al.
NEUROLOGY (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases
Abimael Gonzalez-Hernandez et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response
Matilde Capi et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Optimizing prophylactic treatment of migraine: Subtypes and patient matching
Michel Dib
Therapeutics and Clinical Risk Management (2016)
Triazole rizatriptan Induces Liver Toxicity through Lysosomal/Mitochondrial Dysfunction
J. K. Fard et al.
DRUG RESEARCH (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Drug safety in acute migraine treatment
Janos Tajti et al.
EXPERT OPINION ON DRUG SAFETY (2015)
The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
Michael J. Marmura et al.
HEADACHE (2015)
CGRP antibodies: the Holy Grail for migraine prevention?
Julio Pascual
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein
Sieneke Labruijere et al.
CEPHALALGIA (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review
Maria L. Westergaard et al.
CEPHALALGIA (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine
Jerome Goldstein et al.
CEPHALALGIA (2014)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity
Flavia Napoletano et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
An Ongoing Role of α-Calcitonin Gene-Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
Sarah-Jane Smillie et al.
HYPERTENSION (2014)
Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure
Tu H. Mai et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
Sarah Walter et al.
MABS (2014)
DrugBank 4.0: shedding new light on drug metabolism
Vivian Law et al.
NUCLEIC ACIDS RESEARCH (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status
Maria Lurenda Westergaard et al.
PAIN (2014)
Involvement of gap junction channels in the pathophysiology of migraine with aura
Denis Sarrouilhe et al.
FRONTIERS IN PHYSIOLOGY (2014)
Migraine: The seventh disabler
T. J. Steiner et al.
CEPHALALGIA (2013)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Medicinal Chemistry of Antimigraine Drugs
K. Tekes et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs
Martha B. Ramirez Rosas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
Yong Hu et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Role of 5-HT1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn
Hyo-Jin Jeong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pathophysiology of Medication-overuse Headache: Implications from Animal Studies
Saknan Bongsebandhu-Phubhakdi et al.
CURRENT PAIN AND HEADACHE REPORTS (2012)
Pharmacological evidence that spinal α2C- and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation
Carlos M. Villalon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors
Bruno A. Marichal-Cancino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
Carl Dahlof et al.
HEADACHE (2012)
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Markus Farkkila et al.
LANCET NEUROLOGY (2012)
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. Holland et al.
NEUROLOGY (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Basic mechanisms of migraine and its acute treatment
Lars Edvinsson et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Adherence with Migraine Prophylaxis in Clinical Practice
Ariel Berger et al.
PAIN PRACTICE (2012)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Possible site of action of CGRP antagonists in migraine
Peer Tfelt-Hansen et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
Kayi Y. Chan et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers
Milena De Felice et al.
BRAIN (2010)
Cortical hyperexcitability and mechanism of medication-overuse headache
Weera Supornsilpchai et al.
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Sudden Cardiac Death Prediction and Prevention Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop
Glenn I. Fishman et al.
CIRCULATION (2010)
Does sumatriptan cross the blood-brain barrier in animals and man?
Peer Carsten Tfelt-Hansen
JOURNAL OF HEADACHE AND PAIN (2010)
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
K. Y. Chan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Clinical features, pathophysiology, and treatment of medication-overuse headache
Stefan Evers et al.
LANCET NEUROLOGY (2010)
Propranolol blocks cardiac and neuronal voltage-gated sodium channels
Dao W. Wang et al.
FRONTIERS IN PHARMACOLOGY (2010)
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
Inger L. Meek et al.
PHARMACEUTICALS (2010)
Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study
C. G. H. Dahlof et al.
CEPHALALGIA (2009)
CGRP receptors in the control of pain and inflammation
Silvia Benemei et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries
Kayi Y. Chan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Origin of pain in migraine: evidence for peripheral sensitisation
Jes Olesen et al.
LANCET NEUROLOGY (2009)
Levels of evidence Taking Neurology® to the next level
Robert A. Gross et al.
NEUROLOGY (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Carlos M. Villalon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The blood-brain barrier in migraine treatment
L. Edvinsson et al.
CEPHALALGIA (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial
C. V. S. Lakshmi et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
The discovery of a new drug class for the acute treatment of migraine
Patrick P. A. Humphrey
HEADACHE (2007)
Clonidine inhibits the canine external carotid vasodilatation to capsaicin by α2A/2c-adrenoceptors
Luisa R. Jimenez-Mena et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform
Floris H. M. Vanmolkot et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Characterisation of CGRP receptors in human and porcine isolated coronary arteries:: Evidence for CGRP receptor heterogeneity
S Gupta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Cost of disorders of the brain in Europe
P Andlin-Sobocki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Triptans induce vasoconstriction of human arteries and veins from the thoracic wall
A Wackenfors et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Naratriptan in the short-term prophylaxis of pure menstrual migraine
F Moschiano et al.
NEUROLOGICAL SCIENCES (2005)
Regional expression of 5-HT1B receptor mRNA in the human brain
K Varnäs et al.
SYNAPSE (2005)
[3H]LY334370, a novel radioligand for the 5-HT1F receptor.: II.: Autoradiographic localization in rat, guinea pig, monkey and human brain
VL Lucaites et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
D Dodick et al.
HEADACHE (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Non-opioid analgesics for perioperative pain therapy.: Risks and rational basis for application
A Brack et al.
ANAESTHESIST (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
5-HT1B receptors, α2A/2C- and, to a lesser extent, α1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs
LF Valdivia et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
The PROMISE study: PROphylaxis of MIgraine with SEglor (R) (Dihydroergotamine mesilate) in French primary care
A Pradalier et al.
CNS DRUGS (2004)
Ergotamine and dihydroergotamine: History, pharmacology, and efficacy
SD Silberstein et al.
HEADACHE (2003)
Features of medication overuse headache following overuse of different acute headache drugs
V Limmroth et al.
NEUROLOGY (2002)
Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery
D Akin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Elevated sympathetic nervous activity in mice deficient in αCGRP
Y Oh-hashi et al.
CIRCULATION RESEARCH (2001)
Addiction and the brain: The neurobiology of compulsion and its persistence
SE Hyman et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes
AA Parsons et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Tolerability of sumatriptan: clinical trials and post-marketing experience
KMA Welch et al.
CEPHALALGIA (2000)
Intravenous valproate sodium (Depacon) aborts migraine rapidly: A preliminary report
NT Mathew et al.
HEADACHE (2000)
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches
JNJM de Hoon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Efficacy of naratriptan tablets in the acute treatment of migraine:: A dose-ranging study
H Havanka et al.
CLINICAL THERAPEUTICS (2000)
Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453
MI Smith et al.
CEPHALALGIA (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
